CATALIST-LISTED incubator The Trendlines Group set up four more medical technology (medtech) startups in Singapore in 2018, including tie-ups with the National Healthcare Group and A*ccelerate, the commercialisation arm of the Agency for Science, Technology and Research (A*Star).

SINGAPORE (Jan 16): Trendlines Group says its new US$40 million Singapore venture fund ($54.2 million) has been appointed as a partner under the Startup SG Equity scheme, which is administered by Enterprise Singapore investment arm Seeds Capital. To recap, Seeds Capital issued a call for proposals ...

The seven co-investors are AgFunder, Hatch, ID Capital, Openspace Ventures, The Yield Lab, Trendlines and Visvires New Protein. The post SG’s SEEDS Capital, partners to co-invest $66.6m in agtech startups appeared first on DealStreetAsia.

THE following companies saw new developments that may affect trading of their shares on Wednesday:

THE Trendlines Group on Tuesday said it intends to open a Singapore-based innovation centre focused on developing agrifood technologies, and is planning to raise a US$40 million venture fund to invest in and support early-stage agrifood tech.

SINGAPORE (Dec 18): The Trendlines Group announced Tuesday it plans to open a Singapore-based innovation centre focused on developing agrifood technologies. In addition, Trendlines says it wants to raise a US$40 million venture fund to support the new investment activity, and act as the new fund’...

AFTER making headway into the agritech scene in Israel, having amassed 21 companies in its portfolio, Catalist-listed startup incubator Trendlines is now shifting its focus to Singapore, said its chief executive officer Steve Rhodes.

A*ccelerate is forging partnerships with investors such as Startup-O, Hafnium Hafaway, Marvelstone, Trendlines and Dymon Asia Ventures. The post Singapore: A*STAR arm partners investors to raise $62m, back deep tech startups appeared first on DealStreetAsia.

SINGAPORE'S Agency for Science, Technology and Research’s (A*Star) newly-rebranded commercialisation arm, A*ccelerate, will be entering into new agreements with investors such as Startup-O, Hafnium Hafaway, Marvelstone, Trendlines and Dymon Asia Ventures.